CyanVac CEO Speaks at White House Summit on the Future of COVID-19 Vaccines
/PRNewswire/ -- CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a proprietary transformational parainfluenza virus 5...
Source: prnewswire.com